Management tracks

Rare disease company Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) hired Mary Szela as CEO. Sandford Smith had been interim CEO since Marc Beer's resignation in July 2015. Szela was

Read the full 275 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE